MICRO THERAPEUTICS
Micro Therapeutics provides invasive medical devices for the diagnosis and treatment of vascular diseases. It provides devices pertaining to the treatment of neurovascular disorders of the brain associated with stroke. It is also focused on the treatment of peripheral vascular disease, including blood clot therapy in hemodialysis access grafts, arteries, and veins. Its neurovascular product portfolio includes Sapphire and Sapphire NXT detachable coils that were developed to treat brain ane... urysms; Onyx, which is a liquid embolic that was developed to treat brain aneurysms and arterial-venous malformations; and delivery products, including guidewires, balloon catheters, and micro catheters, and more. It also provides a mechanical thrombolytic device for interventional clot disruption and dissolution. Micro Therapeutics was established in 1968, based in Irvine, California. It delivers its products to radiologists and neuroradiologists primarily in the United States, Canada, the European Union, and Japan. Micro Therapeutics currently operates as a subsidiary of Covidien plc.
MICRO THERAPEUTICS
Industry:
Health Care Health Diagnostics Medical Therapeutics
Founded:
1968-01-01
Address:
Irvine, California, United States
Country:
United States
Status:
Active
Similar Organizations
Advanced vascular Therapies
Advanced vascular Therapies provides non-invasive choices to individuals with poor circulation.
Medtronic
Medtronic develops and manufactures medical device technologies and therapies to treat chronic diseases worldwide.
Metabolic Testing Services
MET-TEST offers a higher level of diagnostic insight to improve management of cardiac and pulmonary diseases.
MRI Robotics
MRI Robotics is dedicated to advanced medical devices for the diagnosis and treatment of cancer.
Target Therapeutics
Target Therapeutics develops disposable medical devices for use in minimally-invasive procedures that are used to treat vascular diseases.
Transmural Systems
Transmural Systems is a medical devices company with a platform of percutaneous structural heart therapies for cardiovascular diseases.
Zerusa
Zerusa Limited designs, develops and markets minimally invasive medical devises for the diagnosis and treatment of vascular disease.
Founder
